Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 71 entries
Sorted by: Best Match Show Resources per page
Recent oral antidiabetics.

The Journal of the Christian Medical Association of India

ISWARIAH V.
PMID: 13664747
J Christ Med Assoc India. 1959 May;34(3):162-5.

No abstract available.

Cite
ISWARIAH V. Recent oral antidiabetics. J Christ Med Assoc India. 1959;34(3):162-5
ISWARIAH, V. (1959). Recent oral antidiabetics. The Journal of the Christian Medical Association of India, 34(3), 162-5.
ISWARIAH, V. "Recent oral antidiabetics." The Journal of the Christian Medical Association of India vol. 34,3 (1959): 162-5.
ISWARIAH V. Recent oral antidiabetics. J Christ Med Assoc India. 1959 May;34(3):162-5. PMID: 13664747.
Copy Download .nbib Format: NLM
[Clinical notes after 16 months of therapeutic experience with sulfanylureas].

Minerva medica

MASSOBRIO E, BOGLIONE G.
PMID: 13552300
Minerva Med. 1958 Apr 18;49(31):1478-9.

No abstract available.

Cite
MASSOBRIO E, BOGLIONE G. Considerazioni cliniche dopo 16 mesi di esperienza terapeutica con le sulfaniluree. [Clinical notes after 16 months of therapeutic experience with sulfanylureas]. Minerva Med. 1958;49(31):1478-9
MASSOBRIO, E., & BOGLIONE, G. (1958). Considerazioni cliniche dopo 16 mesi di esperienza terapeutica con le sulfaniluree. [Clinical notes after 16 months of therapeutic experience with sulfanylureas]. Minerva medica, 49(31), 1478-9.
MASSOBRIO, E, and BOGLIONE, G. "Considerazioni cliniche dopo 16 mesi di esperienza terapeutica con le sulfaniluree." [Clinical notes after 16 months of therapeutic experience with sulfanylureas]. Minerva medica vol. 49,31 (1958): 1478-9.
MASSOBRIO E, BOGLIONE G. Considerazioni cliniche dopo 16 mesi di esperienza terapeutica con le sulfaniluree. [Clinical notes after 16 months of therapeutic experience with sulfanylureas]. Minerva Med. 1958 Apr 18;49(31):1478-9. Italian. PMID: 13552300.
Copy Download .nbib Format: NLM
[Early results of P-607 or chloropropamide therapy of diabetes mellitus; preliminary note].

Portugal medico

DE SALCEDO I, BORGES F.
PMID: 13567157
Port Med. 1958 Jun;42(6):377-80.

No abstract available.

Cite
DE SALCEDO I, BORGES F. Resultados preliminares do tratamento da diabete mellitus pelo P-607 ou cloropropamida; nota prévia. [Early results of P-607 or chloropropamide therapy of diabetes mellitus; preliminary note]. Port Med. 1958;42(6):377-80
DE SALCEDO, I., & BORGES, F. (1958). Resultados preliminares do tratamento da diabete mellitus pelo P-607 ou cloropropamida; nota prévia. [Early results of P-607 or chloropropamide therapy of diabetes mellitus; preliminary note]. Portugal medico, 42(6), 377-80.
DE SALCEDO, I, and BORGES, F. "Resultados preliminares do tratamento da diabete mellitus pelo P-607 ou cloropropamida; nota prévia." [Early results of P-607 or chloropropamide therapy of diabetes mellitus; preliminary note]. Portugal medico vol. 42,6 (1958): 377-80.
DE SALCEDO I, BORGES F. Resultados preliminares do tratamento da diabete mellitus pelo P-607 ou cloropropamida; nota prévia. [Early results of P-607 or chloropropamide therapy of diabetes mellitus; preliminary note]. Port Med. 1958 Jun;42(6):377-80. Portuguese. PMID: 13567157.
Copy Download .nbib Format: NLM
Oral hypoglycemic agents.

The Journal of the Indiana State Medical Association

LUKEMEYER GT.
PMID: 13588046
J Indiana State Med Assoc. 1958 Oct;51(10):1379-84.

No abstract available.

Cite
LUKEMEYER GT. Oral hypoglycemic agents. J Indiana State Med Assoc. 1958;51(10):1379-84
LUKEMEYER, G. T. (1958). Oral hypoglycemic agents. The Journal of the Indiana State Medical Association, 51(10), 1379-84.
LUKEMEYER, G T. "Oral hypoglycemic agents." The Journal of the Indiana State Medical Association vol. 51,10 (1958): 1379-84.
LUKEMEYER GT. Oral hypoglycemic agents. J Indiana State Med Assoc. 1958 Oct;51(10):1379-84. PMID: 13588046.
Copy Download .nbib Format: NLM
Oral therapy for diabetes mellitus.

Virginia medical monthly

Moss JM.
PMID: 5930266
Va Med Mon (1918). 1966 May;93(5):257-9.

No abstract available.

Cite
Moss JM. Oral therapy for diabetes mellitus. Va Med Mon (1918). 1966;93(5):257-9
Moss, J. M. (1966). Oral therapy for diabetes mellitus. Virginia medical monthly, 93(5), 257-9.
Moss, J M. "Oral therapy for diabetes mellitus." Virginia medical monthly vol. 93,5 (1966): 257-9.
Moss JM. Oral therapy for diabetes mellitus. Va Med Mon (1918). 1966 May;93(5):257-9. PMID: 5930266.
Copy Download .nbib Format: NLM
[Practical aspects of arylsulfonylurea therapy of diabetes].

Revue medicale de la Suisse romande

PLATTNER HC.
PMID: 13634768
Rev Med Suisse Romande. 1959 Feb;79(2):113-24 contd.

No abstract available.

Cite
PLATTNER HC. Aspects pratiques du traitement du diabète par les arylsulfonylurées. [Practical aspects of arylsulfonylurea therapy of diabetes]. Rev Med Suisse Romande. 1959;79(2):113-24 contd
PLATTNER, H. C. (1959). Aspects pratiques du traitement du diabète par les arylsulfonylurées. [Practical aspects of arylsulfonylurea therapy of diabetes]. Revue medicale de la Suisse romande, 79(2), 113-24 contd.
PLATTNER, H C. "Aspects pratiques du traitement du diabète par les arylsulfonylurées." [Practical aspects of arylsulfonylurea therapy of diabetes]. Revue medicale de la Suisse romande vol. 79,2 (1959): 113-24 contd.
PLATTNER HC. Aspects pratiques du traitement du diabète par les arylsulfonylurées. [Practical aspects of arylsulfonylurea therapy of diabetes]. Rev Med Suisse Romande. 1959 Feb;79(2):113-24 contd. French. PMID: 13634768.
Copy Download .nbib Format: NLM
[A year of clinical experience with synthetic hypoglycemic drugs, with special reference to cases treated for over six months].

Minerva medica

FIORIO C.
PMID: 13552306
Minerva Med. 1958 Apr 18;49(31):1485.

No abstract available.

Cite
FIORIO C. Un anno di esperienze cliniche con gli ipoglicemizzanti di sintesi, con speciale riguardo ai casi seguiti per oltre sei mesi. [A year of clinical experience with synthetic hypoglycemic drugs, with special reference to cases treated for over six months]. Minerva Med. 1958;49(31):1485
FIORIO, C. (1958). Un anno di esperienze cliniche con gli ipoglicemizzanti di sintesi, con speciale riguardo ai casi seguiti per oltre sei mesi. [A year of clinical experience with synthetic hypoglycemic drugs, with special reference to cases treated for over six months]. Minerva medica, 49(31), 1485.
FIORIO, C. "Un anno di esperienze cliniche con gli ipoglicemizzanti di sintesi, con speciale riguardo ai casi seguiti per oltre sei mesi." [A year of clinical experience with synthetic hypoglycemic drugs, with special reference to cases treated for over six months]. Minerva medica vol. 49,31 (1958): 1485.
FIORIO C. Un anno di esperienze cliniche con gli ipoglicemizzanti di sintesi, con speciale riguardo ai casi seguiti per oltre sei mesi. [A year of clinical experience with synthetic hypoglycemic drugs, with special reference to cases treated for over six months]. Minerva Med. 1958 Apr 18;49(31):1485. Italian. PMID: 13552306.
Copy Download .nbib Format: NLM
Introduction of biosimilar insulins in Europe.

Diabetic medicine : a journal of the British Diabetic Association

Davies M, Dahl D, Heise T, Kiljanski J, Mathieu C.
PMID: 28608570
Diabet Med. 2017 Oct;34(10):1340-1353. doi: 10.1111/dme.13400. Epub 2017 Jul 16.

Regulatory approval of the first biosimilar insulin in Europe, LY2963016 insulin glargine (Abasaglar

Cite
Davies M, Dahl D, Heise T, et al. Introduction of biosimilar insulins in Europe. Diabet Med. 2017;34(10):1340-1353doi: 10.1111/dme.13400.
Davies, M., Dahl, D., Heise, T., Kiljanski, J., & Mathieu, C. (2017). Introduction of biosimilar insulins in Europe. Diabetic medicine : a journal of the British Diabetic Association, 34(10), 1340-1353. https://doi.org/10.1111/dme.13400
Davies, M, et al. "Introduction of biosimilar insulins in Europe." Diabetic medicine : a journal of the British Diabetic Association vol. 34,10 (2017): 1340-1353. doi: https://doi.org/10.1111/dme.13400
Davies M, Dahl D, Heise T, Kiljanski J, Mathieu C. Introduction of biosimilar insulins in Europe. Diabet Med. 2017 Oct;34(10):1340-1353. doi: 10.1111/dme.13400. Epub 2017 Jul 16. PMID: 28608570; PMCID: PMC5637898.
Copy Download .nbib Format: NLM
[What is happening with the new diabetes mellitus drugs?].

Atencion primaria

Diogène Fadini E, Rodríguez Cumplido D.
PMID: 19394718
Aten Primaria. 2009 May;41(5):238-9. doi: 10.1016/j.aprim.2008.12.006. Epub 2009 Apr 26.

No abstract available.

Cite
Diogène Fadini E, Rodríguez Cumplido D. ¿Qué pasa con los nuevos fármacos para la diabetes mellitus? [What is happening with the new diabetes mellitus drugs?]. Aten Primaria. 2009;41(5):238-9doi: 10.1016/j.aprim.2008.12.006.
Diogène Fadini, E., & Rodríguez Cumplido, D. (2009). ¿Qué pasa con los nuevos fármacos para la diabetes mellitus? [What is happening with the new diabetes mellitus drugs?]. Atencion primaria, 41(5), 238-9. https://doi.org/10.1016/j.aprim.2008.12.006
Diogène Fadini, Eduard, and Rodríguez Cumplido, Dolores. "¿Qué pasa con los nuevos fármacos para la diabetes mellitus?" [What is happening with the new diabetes mellitus drugs?]. Atencion primaria vol. 41,5 (2009): 238-9. doi: https://doi.org/10.1016/j.aprim.2008.12.006
Diogène Fadini E, Rodríguez Cumplido D. ¿Qué pasa con los nuevos fármacos para la diabetes mellitus? [What is happening with the new diabetes mellitus drugs?]. Aten Primaria. 2009 May;41(5):238-9. doi: 10.1016/j.aprim.2008.12.006. Epub 2009 Apr 26. Spanish. PMID: 19394718; PMCID: PMC7021986.
Copy Download .nbib Format: NLM
Diabetes: diabetes therapy and cancer risk.

Nature reviews. Endocrinology

Vigneri R.
PMID: 19924151
Nat Rev Endocrinol. 2009 Dec;5(12):651-2. doi: 10.1038/nrendo.2009.219.

No abstract available.

Cite
Vigneri R. Diabetes: diabetes therapy and cancer risk. Nat Rev Endocrinol. 2009;5(12):651-2doi: 10.1038/nrendo.2009.219.
Vigneri, R. (2009). Diabetes: diabetes therapy and cancer risk. Nature reviews. Endocrinology, 5(12), 651-2. https://doi.org/10.1038/nrendo.2009.219
Vigneri, Riccardo. "Diabetes: diabetes therapy and cancer risk." Nature reviews. Endocrinology vol. 5,12 (2009): 651-2. doi: https://doi.org/10.1038/nrendo.2009.219
Vigneri R. Diabetes: diabetes therapy and cancer risk. Nat Rev Endocrinol. 2009 Dec;5(12):651-2. doi: 10.1038/nrendo.2009.219. PMID: 19924151.
Copy Download .nbib Format: NLM
Management of diabetes mellitus in clinical practice.

British journal of nursing (Mark Allen Publishing)

Lawal M.
PMID: 19186366
Br J Nurs. 2008 Sep 25-Oct 8;17(17):1106-13. doi: 10.12968/bjon.2008.17.17.31109.

Diabetes is a global health problem, with a challenging epidemiology. It is one of the major health problems affecting countries around the world, particularly the UK (World Health Organization [WHO], 2006; Department of Health [DH], 2006b). It is also...

Cite
Lawal M. Management of diabetes mellitus in clinical practice. Br J Nurs. 2008;17(17):1106-13doi: 10.12968/bjon.2008.17.17.31109.
Lawal, M. (2008). Management of diabetes mellitus in clinical practice. British journal of nursing (Mark Allen Publishing), 17(17), 1106-13. https://doi.org/10.12968/bjon.2008.17.17.31109
Lawal, Muili. "Management of diabetes mellitus in clinical practice." British journal of nursing (Mark Allen Publishing) vol. 17,17 (2008): 1106-13. doi: https://doi.org/10.12968/bjon.2008.17.17.31109
Lawal M. Management of diabetes mellitus in clinical practice. Br J Nurs. 2008 Sep 25-Oct 8;17(17):1106-13. doi: 10.12968/bjon.2008.17.17.31109. PMID: 19186366.
Copy Download .nbib Format: NLM
Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study.

Journal of the American Pharmacists Association : JAPhA

Schmittdiel JA, Raebel MA, Dyer W, Xu S, Goodrich GK, Schroeder EB, Segal JB, O' Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Karter AJ, Lafata JE, Butler MG, Steiner JF.
PMID: 24860866
J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):374-82. doi: 10.1331/JAPhA.2014.13195.

OBJECTIVE: To understand the burden of medication use for patients with newly diagnosed diabetes both before and after diabetes diagnosis and to identify subpopulations of patients with newly diagnosed diabetes who face a relatively high drug burden.DESIGN: Retrospective cohort...

Cite
Schmittdiel JA, Raebel MA, Dyer W, et al. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014;54(4):374-82doi: 10.1331/JAPhA.2014.13195.
Schmittdiel, J. A., Raebel, M. A., Dyer, W., Xu, S., Goodrich, G. K., Schroeder, E. B., Segal, J. B., O' Connor, P. J., Nichols, G. A., Lawrence, J. M., Kirchner, H. L., Karter, A. J., Lafata, J. E., Butler, M. G., & Steiner, J. F. (2014). Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. Journal of the American Pharmacists Association : JAPhA, 54(4), 374-82. https://doi.org/10.1331/JAPhA.2014.13195
Schmittdiel, Julie A, et al. "Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study." Journal of the American Pharmacists Association : JAPhA vol. 54,4 (2014): 374-82. doi: https://doi.org/10.1331/JAPhA.2014.13195
Schmittdiel JA, Raebel MA, Dyer W, Xu S, Goodrich GK, Schroeder EB, Segal JB, O' Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Karter AJ, Lafata JE, Butler MG, Steiner JF. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):374-82. doi: 10.1331/JAPhA.2014.13195. PMID: 24860866; PMCID: PMC4161641.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 71 entries